Connect with us

Hi, what are you looking for?

Jewish Business News

Leadership & A-List

Benny Landa: Teva would be wrong to buy Mylan

The Teva shareholder and digital printing pioneer thinks Teva should be investing in innovation, not cheap commodity drugs.

Benny Landa

Benny Landa feels confused. The successful entrepreneur, one of the fathers of Israel’s digital printing equipment industry, does not quite understand why Israel’s Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) insists on acquiring US rival Mylan (MYL).

READ MORE:

In late 2013, Landa became an activist investor in Teva because of his dissatisfaction with the performance of its board of directors, chiefly over the ouster of Jeremy Levin as CEO.

Since then, Phillip Frost has been replaced as chairman of Teva by former Cellcom Israel Ltd. (NYSE:CEL; TASE:CEL) CEO Yitzhak Peterburg, and Erez Vigodman, who formerly headed Makhteshim-Agan, took over as CEO fifteen months ago….

[READ MORE]

 

GLOBES logo-eng (1)

Published by Globes [online], Israel business news – www.globes-online.com

Newsletter



Advertisement

You May Also Like

World News

In the 15th Nov 2015 edition of Israel’s good news, the highlights include:   ·         A new Israeli treatment brings hope to relapsed leukemia...

Entertainment

The Movie The Professional is what made Natalie Portman a Lolita.

Travel

After two decades without a rating system in Israel, at the end of 2012 an international tender for hotel rating was published.  Invited to place bids...

VC, Investments

You may not become a millionaire, but there is a lot to learn from George Soros.

Advertisement